Jeannette M. Watson

GPR105, a novel Gi/o-coupled UDP-glucose receptor expressed on brain glia and peripheral immune cells, is regulated by immunologic challenge: possible role in neuroimmune function

Darren J. Moore, Paul R. Murdock, Jeannette M. Watson et al. · Molecular Brain Research · 2003 · 107 citations

Neuroimmune Function, Autoimmune Disease, G Protein-coupled Receptor +13

The potent M1 receptor allosteric agonist GSK1034702 improves episodic memory in humans in the nicotine abstinence model of cognitive dysfunction

Pradeep J. Nathan, Jeannette M. Watson, Lund Jesper et al. · The International Journal of Neuropsychopharmacology · 2012 · 101 citations

Behavioral Addiction, Psychopharmacology, Nicotine Abstinence Model +17

5‐HT_1A receptor agonist‐antagonist binding affinity difference as a measure of intrinsic activity in recombinant and native tissue systems

Jeannette M. Watson, L Collin, M Ho et al. · British Journal of Pharmacology · 2000 · 76 citations · Full text

Characterization of CP-122,721; a nonpeptide antagonist of the neurokinin NK1 receptor.

Stafford McLean, Alan H. Ganong, Patricia A. Seymour et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 74 citations

Design and Synthesis of<i>trans</i>-3-(2-(4-((3-(3-(5-Methyl-1,2,4-oxadiazolyl))- phenyl)carboxamido)cyclohexyl)ethyl)-7-methylsulfonyl-2,3,4,5-tetrahydro- 1<i>H</i>-3-benzazepine (SB-414796):  A Potent and Selective Dopamine D₃Receptor Antagonist

Gregor J. Macdonald, Clive L. Branch, Michael S. Hadley et al. · Journal of Medicinal Chemistry · 2003 · 72 citations · Full text